Celine Dieval
Rochefort, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Risk of synchronous and second primary malignancies in transplant-ineligible patients with multiple myeloma treated with lenalidomide.
Journal: Blood advances
Published: March 25, 2025
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases.
Journal: Clinical and experimental medicine
Published: June 10, 2022
Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
Journal: The British journal of dermatology
Published: October 07, 2021
Waldenström macroglobulinemia and relationship to immune deficiency.
Journal: Leukemia & lymphoma
Published: June 04, 2021
Carfilzomib weekly 20/56 mg/m2 , lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.
Journal: American journal of hematology
Published: October 03, 2018
Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations.
Journal: Oral surgery, oral medicine, oral pathology and oral radiology
Published: December 26, 2012
Chronic bone pain: myeloid metaplasia
Journal: Presse medicale (Paris, France : 1983)
Published: October 11, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026